O&G Cases · Gynaecological oncology — vagina
Vaginal cancer MDT — staging and treatment-planning station
Staging and treatment-planning station on primary vaginal cancer. Tests the FIGO primary-vaginal definition, the verbatim staging applied to imaging, the radiotherapy-dominant management with brachytherapy, the narrow surgical role, and the HPV field effect. Includes assessor key and marking domains.
On this page
Study tools
Target exams
Station brief
Format. Staging and treatment-planning station, approximately 12 minutes. You are the gynaecology oncology registrar presenting this woman to the multidisciplinary team meeting. The assessor plays the MDT chair and asks you to apply the FIGO definition, stage the tumour, and propose the treatment plan with its rationale. [1]
Candidate instruction. Confirm this is a primary vaginal cancer, assign the FIGO stage from the imaging, and propose the definitive management with drug specifics and the rationale for the chosen modality. Address the HPV field effect in your surveillance plan. [2]
References5ShowHide
- [1]FIGO Committee on Gynecologic Oncology Current FIGO staging for cancer of the vagina, fallopian tube, ovary, and gestational trophoblastic neoplasia. Int J Gynaecol Obstet, 2009.PMID 19322933
- [2]Nogueira-Rodrigues A, Oonk MHM, Lorusso D, Slomovitz B, Leitão MM Jr, Baiocchi G Comprehensive management of vulvovaginal cancers. CA Cancer J Clin, 2025.PMID 40377134
- [3]Jhingran A Updates in the treatment of vaginal cancer. Int J Gynecol Cancer, 2022.PMID 35256422
- [4]Kesic V, Carcopino X, Preti M, Vieira-Baptista P, Bevilacqua F, Bornstein J, et al. The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD), and the European Federation for Colposcopy (EFC) consensus statement on the management of vaginal intraepithelial neoplasia. Int J Gynecol Cancer, 2023.PMID 36958755
- [5]Huang J, Cai M, Zhu Z Survival and prognostic factors in primary vaginal cancer: an analysis of 2004-2014 SEER data. Transl Cancer Res, 2020.PMID 35117314